BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27272717)

  • 1. Coexistence of Copper in the Iron-Rich Particles of Aceruloplasminemia Brain.
    Yoshida K; Hayashi H; Wakusawa S; Shigemasa R; Koide R; Ishikawa T; Tatsumi Y; Kato K; Ohara S; Ikeda SI
    Biol Trace Elem Res; 2017 Jan; 175(1):79-86. PubMed ID: 27272717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial iron distribution and quantification in aceruloplasminemia: A case study.
    Zhou L; Chen Y; Li Y; Gharabaghi S; Chen Y; Sethi SK; Wu Y; Haacke EM
    Magn Reson Imaging; 2020 Jul; 70():29-35. PubMed ID: 32114188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness.
    Kaneko K; Hineno A; Yoshida K; Ohara S; Morita H; Ikeda S
    Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and liver iron accumulation in aceruloplasminemia.
    Fujita K; Osaki Y; Harada M; Kono S; Miyajima H; Izumi Y; Kaji R
    Neurology; 2013 Dec; 81(24):2145-6. PubMed ID: 24323439
    [No Abstract]   [Full Text] [Related]  

  • 5. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging for the quantitative assessment of brain iron in aceruloplasminemia: A postmortem validation study.
    Vroegindeweij LHP; Wielopolski PA; Boon AJW; Wilson JHP; Verdijk RM; Zheng S; Bonnet S; Bossoni L; van der Weerd L; Hernandez-Tamames JA; Langendonk JG
    Neuroimage; 2021 Dec; 245():118752. PubMed ID: 34823024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copper Accumulates in Hemosiderins in Livers of Patients with Iron Overload Syndromes.
    Ono Y; Ishigami M; Hayashi K; Wakusawa S; Hayashi H; Kumagai K; Morotomi N; Yamashita T; Kawanaka M; Watanabe M; Ozawa H; Tai M; Miyajima H; Yoshioka K; Hirooka Y; Goto H
    J Clin Transl Hepatol; 2015 Jun; 3(2):85-92. PubMed ID: 26356991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
    J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceruloplasmin metabolism and function.
    Hellman NE; Gitlin JD
    Annu Rev Nutr; 2002; 22():439-58. PubMed ID: 12055353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
    Parks NE; Vandorpe RA; Moeller JJ
    Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inclusion bodies of aggregated hemosiderins in liver macrophages.
    Hayashi H; Tatsumi Y; Wakusawa S; Shigemasa R; Koide R; Tsuchida KI; Morotomi N; Yamashita T; Kumagai K; Ono Y; Hayashi K; Ishigami M; Goto H; Kato A; Kato K
    Med Mol Morphol; 2017 Dec; 50(4):205-210. PubMed ID: 28631037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
    Stelten BML; van Ommen W; Keizer K
    JAMA Neurol; 2019 Feb; 76(2):229-230. PubMed ID: 30383083
    [No Abstract]   [Full Text] [Related]  

  • 17. A case of hereditary ceruloplasmin deficiency with iron deposition in the brain associated with chorea, dementia, diabetes mellitus and retinal pigmentation: administration of fresh-frozen human plasma.
    Yonekawa M; Okabe T; Asamoto Y; Ohta M
    Eur Neurol; 1999; 42(3):157-62. PubMed ID: 10529542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superficial siderosis associated with aceruloplasminemia. Case report.
    Matsushima A; Yoshida T; Yoshida K; Ohara S; Toyoshima Y; Kakita A; Ikeda S
    J Neurol Sci; 2014 Apr; 339(1-2):231-4. PubMed ID: 24607334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and in silico characterization of a novel compound heterozygosity associated with hereditary aceruloplasminemia.
    Hofmann WP; Welsch C; Takahashi Y; Miyajima H; Mihm U; Krick C; Zeuzem S; Sarrazin C
    Scand J Gastroenterol; 2007 Sep; 42(9):1088-94. PubMed ID: 17710675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic iron overload or cirrhosis may occur in acquired copper deficiency and is likely mediated by hypoceruloplasminemia.
    Thackeray EW; Sanderson SO; Fox JC; Kumar N
    J Clin Gastroenterol; 2011 Feb; 45(2):153-8. PubMed ID: 20502350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.